DK596483A - Laegemidler paa basis af naphthalen eller azanaphthalencarboxamidderivater, naphthalen- eller azanaphthalencarboxamidderivater og fremgangsmaade til deres fremstilling - Google Patents
Laegemidler paa basis af naphthalen eller azanaphthalencarboxamidderivater, naphthalen- eller azanaphthalencarboxamidderivater og fremgangsmaade til deres fremstilling Download PDFInfo
- Publication number
- DK596483A DK596483A DK596483A DK596483A DK596483A DK 596483 A DK596483 A DK 596483A DK 596483 A DK596483 A DK 596483A DK 596483 A DK596483 A DK 596483A DK 596483 A DK596483 A DK 596483A
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- azanaphthalencarboxamide
- naphthalen
- derivatives
- image
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8221758A FR2538388B1 (fr) | 1982-12-24 | 1982-12-24 | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK596483D0 DK596483D0 (da) | 1983-12-23 |
| DK596483A true DK596483A (da) | 1984-06-25 |
Family
ID=9280501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK596483A DK596483A (da) | 1982-12-24 | 1983-12-23 | Laegemidler paa basis af naphthalen eller azanaphthalencarboxamidderivater, naphthalen- eller azanaphthalencarboxamidderivater og fremgangsmaade til deres fremstilling |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US4711890A (da) |
| EP (1) | EP0112776B1 (da) |
| JP (1) | JPS59219260A (da) |
| AT (1) | ATE28401T1 (da) |
| AU (1) | AU575797B2 (da) |
| CA (1) | CA1225992A (da) |
| DE (1) | DE3372579D1 (da) |
| DK (1) | DK596483A (da) |
| ES (1) | ES8502433A1 (da) |
| FR (1) | FR2538388B1 (da) |
| GR (1) | GR82358B (da) |
| HU (1) | HU191745B (da) |
| IL (1) | IL70528A (da) |
| MA (1) | MA19982A1 (da) |
| NO (1) | NO834798L (da) |
| PT (1) | PT77886B (da) |
| SU (1) | SU1255050A3 (da) |
| ZA (1) | ZA839576B (da) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4639454A (en) * | 1985-01-17 | 1987-01-27 | E. I. Du Pont De Nemours And Company | Phenylquinazolinecarboxylic acids and derivatives as cancer chemotherapeutic agents |
| FR2582514B1 (fr) * | 1985-05-30 | 1988-02-19 | Rhone Poulenc Sante | Medicaments a base d'amides, nouveaux amides et leur preparation |
| DK623586A (da) * | 1985-12-27 | 1987-06-28 | Eisai Co Ltd | Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne |
| FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| US4933447A (en) * | 1987-09-24 | 1990-06-12 | Ss Pharmaceutical Co., Ltd. | Quinoline derivatives |
| PT940391E (pt) | 1994-05-27 | 2004-12-31 | Glaxosmithkline Spa | Derivados de quinolina como antagonistas do receptor de taquicinina nk3 |
| IT1270615B (it) * | 1994-07-14 | 1997-05-07 | Smithkline Beecham Farma | Uso di derivati di chinolina |
| US5627193A (en) * | 1995-02-09 | 1997-05-06 | Mitsui Toatsu Chemicals, Inc. | Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds |
| CA2238298A1 (en) * | 1995-11-24 | 1997-06-19 | Luca Francesco Raveglia | Quinoline derivatives |
| GB9524104D0 (en) | 1995-11-24 | 1996-01-24 | Smithkline Beecham Spa | Novel compounds |
| AR004735A1 (es) * | 1995-11-24 | 1999-03-10 | Smithkline Beecham Spa | Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento. |
| KR100225565B1 (ko) * | 1996-12-12 | 1999-10-15 | 유규재 | 초미세 규산 알루미늄염의 제조법 |
| US5998624A (en) * | 1997-05-07 | 1999-12-07 | Emory University | Haloisoquinoline carboxamide |
| FR2778564B1 (fr) * | 1998-05-13 | 2001-07-13 | Sanofi Sa | Utilisation de composes reduisant l'apoptose |
| WO1999058117A1 (fr) * | 1998-05-13 | 1999-11-18 | Sanofi-Synthelabo | Utilisation de composes reduisant l'apoptose |
| DE10035928A1 (de) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| DE10035927A1 (de) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| DE60114227T2 (de) * | 2000-08-16 | 2006-04-20 | Neurogen Corp., Branford | 2,4-substituierte pyridinderivate |
| US20040152727A1 (en) * | 2001-05-18 | 2004-08-05 | Hay Douglas William Pierre | Novel use |
| MXPA05009722A (es) * | 2003-03-10 | 2006-03-09 | Schering Corp | Inhibidores heterociclicos de cinasa: metodos de uso y sintesis. |
| US8541428B2 (en) * | 2006-08-22 | 2013-09-24 | Technion Research And Development Foundation Ltd. | Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof |
| DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| DE102008015032A1 (de) * | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
| DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
| DE102008062878A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte Furancarboxamide und ihre Verwendung |
| EP2907806A1 (en) * | 2014-02-14 | 2015-08-19 | Universita Degli Studi Di Genova | New compounds as selective PDE4D inhibitors |
| JP6498695B2 (ja) | 2014-04-23 | 2019-04-10 | テクニオン・リサーチ・アンド・ディベロップメント・ファウンデーション・リミテッド | キナゾリン骨格系の化合物、医薬組成物およびその使用方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB191210352A (en) * | 1912-01-16 | 1913-05-01 | Hoechst Ag | Manufacture of New Derivatives of Phenyl-cinchoninic Acid and of Homologues and Derivatives thereof. |
| FR1364605A (fr) * | 1962-03-01 | 1964-06-26 | Procédé de préparation d'amides des acides carboxyliques | |
| US3812127A (en) * | 1966-10-31 | 1974-05-21 | Pfizer | 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters |
| US3799929A (en) * | 1972-03-17 | 1974-03-26 | Lilly Co Eli | Cinchoninic acid derivatives |
| FR2525595A1 (fr) * | 1982-04-27 | 1983-10-28 | Pharmuka Lab | Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments |
-
1982
- 1982-12-24 FR FR8221758A patent/FR2538388B1/fr not_active Expired
-
1983
- 1983-12-21 GR GR73304A patent/GR82358B/el unknown
- 1983-12-21 DE DE8383402501T patent/DE3372579D1/de not_active Expired
- 1983-12-21 AT AT83402501T patent/ATE28401T1/de not_active IP Right Cessation
- 1983-12-21 EP EP83402501A patent/EP0112776B1/fr not_active Expired
- 1983-12-22 AU AU22776/83A patent/AU575797B2/en not_active Ceased
- 1983-12-22 JP JP58243082A patent/JPS59219260A/ja active Pending
- 1983-12-22 US US06/564,322 patent/US4711890A/en not_active Expired - Fee Related
- 1983-12-22 HU HU834425A patent/HU191745B/hu unknown
- 1983-12-22 ZA ZA839576A patent/ZA839576B/xx unknown
- 1983-12-22 MA MA20203A patent/MA19982A1/fr unknown
- 1983-12-22 IL IL70528A patent/IL70528A/xx unknown
- 1983-12-23 CA CA000444273A patent/CA1225992A/fr not_active Expired
- 1983-12-23 NO NO834798A patent/NO834798L/no unknown
- 1983-12-23 DK DK596483A patent/DK596483A/da not_active Application Discontinuation
- 1983-12-23 PT PT77886A patent/PT77886B/pt not_active IP Right Cessation
- 1983-12-23 ES ES528364A patent/ES8502433A1/es not_active Expired
- 1983-12-23 SU SU833682598A patent/SU1255050A3/ru active
-
1985
- 1985-08-08 US US06/763,660 patent/US4684652A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HU191745B (en) | 1987-04-28 |
| FR2538388B1 (fr) | 1985-06-21 |
| DK596483D0 (da) | 1983-12-23 |
| ES528364A0 (es) | 1985-01-01 |
| GR82358B (da) | 1984-12-13 |
| IL70528A0 (en) | 1984-03-30 |
| IL70528A (en) | 1987-01-30 |
| DE3372579D1 (en) | 1987-08-27 |
| US4684652A (en) | 1987-08-04 |
| JPS59219260A (ja) | 1984-12-10 |
| EP0112776B1 (fr) | 1987-07-22 |
| PT77886A (fr) | 1984-01-01 |
| AU2277683A (en) | 1984-06-28 |
| EP0112776A3 (en) | 1984-09-12 |
| ES8502433A1 (es) | 1985-01-01 |
| MA19982A1 (fr) | 1984-07-01 |
| US4711890A (en) | 1987-12-08 |
| NO834798L (no) | 1984-06-25 |
| AU575797B2 (en) | 1988-08-11 |
| ZA839576B (en) | 1984-08-29 |
| EP0112776A2 (fr) | 1984-07-04 |
| FR2538388A1 (fr) | 1984-06-29 |
| PT77886B (fr) | 1986-04-09 |
| ATE28401T1 (de) | 1987-08-15 |
| CA1225992A (fr) | 1987-08-25 |
| SU1255050A3 (ru) | 1986-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK596483A (da) | Laegemidler paa basis af naphthalen eller azanaphthalencarboxamidderivater, naphthalen- eller azanaphthalencarboxamidderivater og fremgangsmaade til deres fremstilling | |
| GB2168053B (en) | Phenoxy-phenyl oxirane compounds | |
| DK238380A (da) | Fremgangsmaade til fremstilling af cycliske imidazolcyanoguanidiner | |
| DK182783D0 (da) | Fremgangsmade til fremstilling af 1-carboxy-(alkanoyl eller aralkanoyl)-indolin-2-carboxylsyreestere eller salte deraf | |
| DK149058C (da) | Analogifremgangsmaade til fremstilling af 4-(4,4-(diphenyl)butyl)-1-acylpiperaziner eller syreadditionssalte deraf | |
| DK160500C (da) | Analogifremgangsmaade til fremstilling af 3-thiomethylpyridinderivater | |
| ATE30725T1 (de) | Heterocyclische phenylaether, verfahren zu deren herstellung und diese enthaltende herbizide mittel. | |
| SE8304315D0 (sv) | Mutteralkaloide, ihre herstellung und verwendung | |
| DK162494C (da) | Analogifremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable salte deraf | |
| DK148058C (da) | Analogifremgangsmaade til fremstilling af thiazolderivater eller syreadditionssalte deraf | |
| ATE30911T1 (de) | Hydrazinopyridazinverbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE17710T1 (de) | Keten-0,0-acetale und verfahren zu ihrer herstellung. | |
| FI893051A (fi) | Oxiraner. | |
| DK207781A (da) | Substituerede oxonicotinater der kan anvendes til regulering af plantevaekst | |
| SE8000138L (sv) | Nya 3-cyklopentan-1,2'(1'h)-naftalen-derivat, framstellning derav och lekemedel innehallande desamma | |
| ATE36157T1 (de) | Azolylierte halogen-keten-o,n-acetale, verfahren zu ihrer herstellung, diese enthaltende fungizide und verfahren zur bekaempfung von pilzen mit ihnen. | |
| DK284080A (da) | Fremgangsmaade til fremstilling af clavulansyrederivater | |
| DK181183A (da) | Cykliske imidatestere og fremgangsmaade til fremstilling deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |